SEATTLE (Feb. 10, 2016) -- A new technology commercialization program will launch this spring to help Washington's life sciences innovators move their promising ideas into the hands of providers and patients, thanks to a $1.8 million "ecosystem" award from the state's Life Sciences Discovery Fund (LSDF).

Led by the Washington Biotechnology & Biomedical Association (WBBA; currently undergoing a name change to Life Science Washington), the program will address key gaps within the state's "commercialization ecosystem" -- the resources needed to advance technologies from the concept stage to the market.